The Quantellect read.As of Nov 19, 2026, 3 active firms cover OKYO Pharma Limited: 3 rate it Buy or better, 0 sit at Neutral, and 0 rate it Sell or worse, a buy consensus. Targets span $5.00 to $7.00, a moderate spread. The average target of $5.67 sits 415% above the current $1.10. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.04 next quarter toward $-0.66 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS3 active firms
Buy
Strong Buy00%
Buy3100%
Neutral00%
Sell00%
Strong Sell00%
Based on 3 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$5.67
+415.2% upside
Average target across 3 active firms as of Nov 19, 2026 vs $1.10 current
Highest Target$7.00
Average Target$5.67
Lowest Target$5.00
Detailed analyst forecasts for OKYO
Showing 1–3 of 3 named analysts shown · 3 active firms in the rating projection
As of Nov 19, 2026, 3 of 3 active firms rate OKYO a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
OKYO EPS & revenue forecast
EPS · NEXT QUARTER
$-0.04
Range $-0.04 – $-0.04 · 1 analysts
Next period, 1 analysts expect OKYO Pharma Limited to earn $-0.04 a share (range $-0.04 – $-0.04), versus — a year earlier. Full-year consensus is $-0.12, growing to $-0.66 the year after.
REVENUE · NEXT QUARTER
—
Range — – — · 1 analysts
Revenue is expected to reach — (range — – —). Full-year consensus is $0, rising to $11.0M next year.
Top analysts covering OKYO Pharma Limited
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on OKYO.
#1
Yi Chen
HC Wainwright & Co. · Rank #350
Buy
$5.00+354.5% to target
Overall win rate
34%
+ Follow
#2
Biren Amin
Piper Sandler
Buy
$7.00+536.4% to target
Coverage
—
+ Follow
#3
WW
William Woods
B. Riley Securities
Buy
$5.00+354.5% to target
Coverage
—
+ Follow
#4
WW
William Wood
B. Riley Securities
Buy
$5.00+354.5% to target
Coverage
—
+ Follow
#5
Elemer Piros
Lucid Capital
Buy
$13.00+1081.8% to target
Coverage
—
+ Follow
OKYO stock forecast FAQ
What is OKYO's average 12-month price target?+
The 3 active firms with a live target average $5.67 for OKYO Pharma Limited over the next 12 months, ranging from a $7.00 high to a $5.00 low, as of Nov 19, 2026.
Is OKYO stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 3 active firms as of Nov 19, 2026, 3 rate it Buy or Strong Buy, 0 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for OKYO?+
The Street-high target is $7.00 (Piper Sandler), and the Street-low is $5.00 (HC Wainwright & Co.). The average of all 3 active-firm targets is $5.67.
How many active Wall Street firms cover OKYO?+
3 active firms have a recognized rating on OKYO Pharma Limited as of Nov 19, 2026, and 3 active firms carry a live 12-month price target.
Who is the most accurate analyst covering OKYO?+
Among analysts who currently cover OKYO, Yi Chen of HC Wainwright & Co. has the strongest overall Quantellect track record (Rank #350). Their current call is Buy with a $5.00 target.
What is OKYO Pharma Limited's projected EPS for next quarter?+
The consensus estimate is $-0.04 per share (range $-0.04 – $-0.04) across 1 analysts. Full-year EPS is projected at $-0.12, rising to $-0.66 the following year.
How much revenue is OKYO Pharma Limited expected to report next quarter?+
Consensus revenue is — (range — – —). Full-year revenue is projected at $0, growing to $11.0M next year.
Have analysts been upgrading or downgrading OKYO lately?+
As of Nov 19, 2026, 3 of 3 active firms rate OKYO a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their OKYO calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.